
Vineet Laboratories: CRISIL Monitoring Report for Rights Issue Funds Q1 FY27
Vineet Laboratories Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report, issued by CRISIL Ratings Limited, details the utilization of funds raised through the company's Rights Issue. CRISIL, appointed as the Monitoring Agency, has provided its assessment as per SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report confirms that there were no deviations from the stated objects of the issue and no specific range of deviation was applicable. The filing includes a declaration from CRISIL stating the report is based on information provided by the issuer and believed to be accurate, while clarifying that it does not constitute an audit or independent verification.
Key Highlights
- CRISIL Ratings issued monitoring report for Vineet Laboratories' Rights Issue funds.
- Report covers utilization of funds for the quarter ended June 30, 2026.
- No deviations from the objects of the Rights Issue were reported.
- CRISIL acts as Monitoring Agency as per SEBI ICDR Regulations.
- Report based on issuer-provided information, not an audit.
Price Impact
More from VINEETLAB